Long-term response to interferon-á in a patient with systemic mastocytosis and chronic myelomonocytic leukemia
✍ Scribed by Marc Pulik; Francois Lionnet; Antoine Petit; Philippe Genet; Alain Gaulier
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 123 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Forming Assay From CD34 + Bone Marrow Cells Serum a BFU-E/10 2 CD34 + cells Control 1 50.2 ± 4.6 Control 2 48.5 ± 14.1 Before chemotherapy 24.4 ± 6.2 b After chemotherapy 50.5 ± 6.5 Values are means ± SD of triplicate cultures. a Control 1; normal AB serum, Control 2; serum from a patient with AILD-
A patient with chronic myeloid leukemia (CML) treated with interferon alpha (IFN alpha) and who developed autoimmune hepatitis (AIH) is described. The patient was treated with IFN alpha 2a, a complete cytogenetic response was achieved 5 months later, and this response has lasted now more than 7 year